iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 prescription trends through June MintPrimer | Despite a surge

Wegovy is a once-weekly injection for obesity treatment approved by the Ministry of Food and Drug Safety in April 2023 as an adjunct to a calorie-reduced diet and increased physical activity for weight loss and weight management in obese patients with an initial body mass index (BMI) of 30 kg/m2 or greater, or in overweight patients with an initial BMI of 27 kg/m2 or greater but less than 30 kg/m2 and one or more weight-related comorbidities -- such as dysglycemia (pre-diabetes or type 2 diabetes), hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease

Unlike oral medications that require daily timing precision, semaglutide's once-weekly injection schedule offers flexibilitybut choosing a consistent day and time strengthens habit formation and helps you track tolerability patterns

That means knowing how much L-Carnitine for weight loss is right for you, understanding when to take L-Carnitine for weight loss based on your daily schedule and workouts, and choosing the best form that your body can actually use

Reduce BMI by an average of 4.76 kg/m over 6 months